Association between MTR A2756G polymorphism and childhood acute lymphoblastic leukemia: a meta-analysis

Jia Xia1, Yadan Wang, Hang Zhang

  • 1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei , China.

Leukemia & Lymphoma
|August 3, 2013
PubMed

Insights

The methionine synthase (MTR) A2756G gene variant is associated with a reduced risk of childhood acute lymphoblastic leukemia (ALL). This finding suggests a protective effect of the MTR A2756G polymorphism against ALL development in children.

Area of Science:

  • Genetics
  • Pediatric Oncology
  • Molecular Biology

Background:

  • The association between methionine synthase (MTR) A2756G polymorphism and childhood acute lymphoblastic leukemia (ALL) has yielded inconsistent results.
  • Clarifying this genetic link is crucial for understanding ALL risk factors.

Purpose of the Study:

  • To conduct a comprehensive meta-analysis to determine the effect of the MTR A2756G polymorphism on the risk of childhood ALL.

Main Methods:

  • A meta-analysis was performed on relevant published studies.
  • Fixed effects models were used to analyze the association between MTR A2756G genotypes and childhood ALL risk.
  • Subgroup analyses were conducted on populations with similar genetic backgrounds.

Main Results:

  • The 2756A allele showed a decreased risk of childhood ALL compared to the G allele (OR = 0.872, P = 0.015).
  • Dominant models (AA vs. AG and AA vs. AG + GG) also indicated a significant reduction in ALL risk (OR = 0.869, P = 0.040 and OR = 0.858, P = 0.020, respectively).
  • Subgroup analysis confirmed a reduced risk in individuals with the AA genotype compared to the AG genotype.

Conclusions:

  • The MTR A2756G polymorphism is associated with a reduced risk of developing childhood ALL.
  • This genetic variant may play a protective role in the etiology of childhood ALL.